Ratings by Rodman & Renshaw (Brandon Folkes)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/25/2025 | CorMedix | CRMD | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2025 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2025 | Adial Pharmaceuticals Inc | ADIL | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2025 | Cardiol Therapeutics | CRDL | New Coverage | Buy (N/A) |
1.29 (1.42) |
10.08% | Details | |
| 1/28/2025 | Indivior | INDV | New Coverage | Buy (N/A) |
12.02 (38.82) |
222.96% | Details | |
| 1/28/2025 | Rein Therapeutics | RNTX | New Coverage | Buy (N/A) |
2.10 (0.82) |
-60.95% | Details | |
| 1/28/2025 | PolyPid Ltd. | PYPD | New Coverage | Buy (N/A) |
3.15 (4.84) |
53.65% | Details | |
| 1/28/2025 | Talphera | TLPH | New Coverage | Buy (N/A) |
0.72 (1.43) |
98.61% | Details | |
| 11/14/2024 | Rockwell Medical Technologies | RMTI | New Coverage | Buy (N/A) |
2.63 (7.14) |
171.48% | Details | |
| 11/14/2024 | Eupraxia Pharmaceuticals | EPRX | New Coverage | Buy (N/A) |
2.84 (6.77) |
138.38% | Details | |
| 11/14/2024 | Achieve Life Sciences | ACHV | New Coverage | Buy (N/A) |
4.53 (6.65) |
46.8% | Details | |
| 11/14/2024 | Adial Pharmaceuticals Inc | ADIL | New Coverage | Buy (N/A) |
0.99 (3.98) |
302.02% | Details | |
| 11/14/2024 | Omeros Corp. | OMER | New Coverage | Buy (N/A) |
4.19 (13.25) |
216.23% | Details | |
| 8/26/2024 | CorMedix | CRMD | New Coverage | Buy (N/A) |
5.65 (7.44) |
31.68% | Details | |
| 6/13/2024 | Trevi Therapeutics | TRVI | New Coverage | Buy (N/A) |
2.60 (18.51) |
611.92% | Details | |
| 6/13/2024 | Scilex Holding Co. | SCLX | New Coverage | Buy (N/A) |
1.33 (6.95) |
422.56% | Details | |
| 6/13/2024 | Heron Therapeutics | HRTX | New Coverage | Buy (N/A) |
3.64 (0.49) |
-86.54% | Details | |
| 6/13/2024 | Rani Therapeutics Holdsing s | RANI | New Coverage | Buy (N/A) |
4.01 (0.79) |
-80.3% | Details | |
| 6/13/2024 | MannKind | MNKD | New Coverage | Buy (N/A) |
4.65 (4.11) |
-11.61% | Details |
